Orion Corp (ORNBV) - Financial and Strategic SWOT Analysis Review
June 2019
61
About the Report
About the Report
Orion Corp (ORNBV)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities-A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Orion Corp (Orion) develops, manufactures and markets human and veterinary pharmaceuticals, and active pharmaceutical ingredients (APIs). Its products include pharmaceuticals for the treatment of central nervous system disorders, cancer, and respiratory diseases. The company's pipeline encompasses investigational candidates for the treatment of amyotrophic lateral sclerosis, Parkinson's disease, chronic obstructive pulmonary disease, and various cancer types. Orion's client base consists of healthcare service providers and professionals, such as doctors, pharmacies, veterinarians, hospitals, healthcare centers, clinics and laboratories. The company sells its products in European markets through own human pharmaceuticals sales organization; and in international markets through several collaboration partners. Orion is headquartered in Espoo, Finland.
Orion Corp Key Recent Developments
Apr 25,2019: Orion Group Interim report January-March 2019
Apr 11,2019: Fire at Orion's manufacturing plant in Turku
Mar 08,2019: New initiative for rare diseases launched by Finnish pharmaceutical company
Feb 26,2019: Orion offers nine months of free platform access and training to PortfolioCenter Users
Feb 06,2019: Orion Group financial statement release for 2018
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Orion Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Companies
Tasly Pharmaceuticals Inc
Merck & Co Inc
GlaxoSmithKline Plc
F. Hoffmann-La Roche Ltd
Biotie Therapies Corp
Biohit Oyj
Abbott Laboratories
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1-About the Company
Orion Corp-Key Facts
Orion Corp-Key Employees
Orion Corp-Key Employee Biographies
Orion Corp-Major Products and Services
Orion Corp-History
Orion Corp-Company Statement
Orion Corp-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2-Company Analysis
Company Overview
Orion Corp-Business Description
Product Category: Animal Health
Overview
Performance
Product Category: Contract Manufacturing
Overview
Performance
Product Category: Fermion
Overview
Performance
Product Category: Proprietary Products
Overview
Performance
Product Category: Specialty Products
Overview
Performance
Product Category: Pharmaceuticals
Overview
Performance
Key Stats
Geographical Segment: Finland
Performance
Geographical Segment: North America
Performance
Geographical Segment: Other Countries
Performance
Geographical Segment: Other Europe
Performance
Geographical Segment: Scandinavia
Performance
R&D Overview
Orion Corp-Corporate Strategy
Orion Corp-SWOT Analysis
SWOT Analysis-Overview
Orion Corp-Strengths
Orion Corp-Weaknesses
Orion Corp-Opportunities
Orion Corp-Threats
Orion Corp-Key Competitors
Section 3-Company Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Performance Chart
Financial Performance
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Section 4-Company's Lifesciences Financial Deals and Alliances
Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Orion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Orion Corp, Recent Deals Summary
Section 5-Company's Recent Developments
Apr 25, 2019: Orion Group Interim report January-March 2019
Apr 11, 2019: Fire at Orion's manufacturing plant in Turku
Mar 08, 2019: New initiative for rare diseases launched by Finnish pharmaceutical company
Feb 26, 2019: Orion offers nine months of free platform access and training to PortfolioCenter Users
Feb 06, 2019: Orion Group financial statement release for 2018
Jan 09, 2019: Recommendation by the nomination committee concerning Board of Directors to be elected by the 2019 AGM of Orion Corporation
Jan 04, 2019: Orion and Fifth Corner join forces to research solutions for improving the quality of life of prostate cancer patients
Nov 01, 2018: Orion Research Foundation grants million euros for research in 2019
Sep 19, 2018: Changes in responsibility areas of the Orion Group executive management board
Sep 17, 2018: Creation of novel medicines and better patient care for the future in an ecosystem
Section 6-Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Orion Corp, Performance Chart (2014-2018)
Orion Corp, Ratio Charts
Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Orion Corp, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
List of Table
List of Tables
Orion Corp, Key Facts
Orion Corp, Key Employees
Orion Corp, Key Employee Biographies
Orion Corp, Major Products and Services
Orion Corp, History
Orion Corp, Subsidiaries
Orion Corp, Key Competitors
Orion Corp, Ratios based on current share price
Orion Corp, Annual Ratios
Orion Corp, Annual Ratios (Cont...1)
Orion Corp, Annual Ratios (Cont...2)
Orion Corp, Interim Ratios
Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Orion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Orion Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.